Six-month, prospective, longitudinal, open-Label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement-Reference-Cited by-同舟云学术

Six-month, prospective, longitudinal, open-Label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement

Published:2008-09 Issue:9 Volume:30 Page:1687-1699
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Kennedy Mary Jayne,Davis Daniel A.,Smith Ned,Gaedigk Andrea,Pearce Robin E.,Kearns Gregory L.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency;Lindsay;J Pediatr,1994

2. Etiologies of short stature among children in public growth screening clinics;Frindik;Clin Res,1990

3. Update of the guidelines for the use of growth hormone in children: The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee;Wilson;J Pediatr,2003

4. Effect of human growth hormone on amobarbital metabolism in children;Redmond;Clin Pharmacol Ther,1978

5. Effects of growth hormone on antipyrine kinetics in children;Rifkind;Clin Pharmacol Ther,1981

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling;Pediatric Research;2019-10-10

2. The clinical toxicology of caffeine: A review and case study;Toxicology Reports;2018

3. A review of current models for initiating injectable therapy for people with type 2 diabetes in primary care;Journal of Clinical & Translational Endocrinology;2017-06

4. Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children;Expert Opinion on Drug Metabolism & Toxicology;2011-05-08

5. Hormonal Regulation of Hepatic Drug-Metabolizing Enzyme Activity During Adolescence;Clinical Pharmacology & Therapeutics;2008-10-29